+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Results for tag: "Subcutaneous Immunoglobulin"

From
From
Subcutaneous Immunoglobulin (SCIG) Global Market Report 2024 - Product Thumbnail Image

Subcutaneous Immunoglobulin (SCIG) Global Market Report 2024

  • Report
  • August 2024
  • 175 Pages
  • Global
From
From
From
From
Intravenous Immunoglobulin Market Report 2025 - Product Thumbnail Image

Intravenous Immunoglobulin Market Report 2025

  • Report
  • February 2025
  • 200 Pages
  • Global
From
Plasma Protein Therapeutics Market Report 2025 - Product Thumbnail Image

Plasma Protein Therapeutics Market Report 2025

  • Report
  • February 2025
  • 200 Pages
  • Global
From
Immunoglobulins Market Report 2025 - Product Thumbnail Image

Immunoglobulins Market Report 2025

  • Report
  • February 2025
  • 200 Pages
  • Global
From
From
Plasma Fractionation Market Report 2025 - Product Thumbnail Image

Plasma Fractionation Market Report 2025

  • Report
  • February 2025
  • 200 Pages
  • Global
From
From
Immunoglobulins: Global Market Outlook - Product Thumbnail Image

Immunoglobulins: Global Market Outlook

  • Report
  • March 2023
  • 64 Pages
  • Global
From
From
Immunoglobulins Market - Global Outlook & Forecast 2021-2026 - Product Thumbnail Image

Immunoglobulins Market - Global Outlook & Forecast 2021-2026

  • Report
  • September 2021
  • 262 Pages
  • Global
From
Loading Indicator

The Subcutaneous Immunoglobulin (SCIg) market is a segment of the Immune Disorders Drugs market. SCIg is a form of immunoglobulin therapy used to treat a variety of immune-mediated diseases, such as primary immunodeficiencies, autoimmune diseases, and chronic inflammatory diseases. SCIg is administered through subcutaneous injections, which are less painful and more convenient than intravenous infusions. SCIg is also more cost-effective than intravenous immunoglobulin (IVIg). SCIg is a rapidly growing market, driven by the increasing prevalence of immune-mediated diseases and the growing demand for more convenient and cost-effective treatments. The market is expected to continue to grow in the coming years, as more patients are diagnosed with immune-mediated diseases and as new treatments become available. Some of the major players in the SCIg market include CSL Behring, Grifols, Kedrion, Octapharma, and Shire. Show Less Read more